CTOs on the Move

Genalyte

www.genalyte.com

 
Since 2007, Genalyte has been guided by the vision of taking a single drop of blood, performing panels of tests and returning accurate and reproducible results within a few minutes. We launched our first instrument in 2012 in the pharmaceutical industry and academia for a range of healthcare applications including autoimmune disease monitoring, screening of cancer biomarkers, testing for infectious agents and detecting anti-drug antibodies. By reducing tests to a microscopic size in a highly multiplex environment on the surface of silicon chips we are able to generate more information from a smaller sample in less time than conventional ...
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.genalyte.com
  • 10520 Wateridge Cir
    San Diego, CA USA 92121
  • Phone: 858.956.1200

Executives

Name Title Contact Details

Funding

Genalyte raised $44M on 08/18/2015
Genalyte raised $36M on 11/19/2016
Genalyte raised $50M on 01/11/2021

Similar Companies

ENABLE Healthcare Communications

ENABLE Healthcare Communications is a Herndon, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Zant

An innovative healthcare platform offering quick and simple access to a vast portfolio of mental health providers. Through the mobile app available on both iOS and Android, individuals can access professionals covering over 25 categories of support at low costs with discounted student and standard rates. At zant, we are dedicated to creating a world where mental health services are accessible, affordable, and available to all.

Salud Dorada con Medicare

Salud Dorada con Medicare is a Bayamon, PR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Telesta Therapeutics

Telesta Therapeutics is a biopharmaceutical company focused on the development, manufacturing and commercialization of transformative human therapeutics. Our main focus is on novel medicines that address major unmet medical needs, particularly in oncology. Our anchor product, MCNA, has completed a Phase III pivotal study in patients with non-muscle invasive bladder cancer that have failed the first line therapy, bacillus Calmette-Guérin (BCG). Telesta submitted a Biologics Licensing Application (BLA) for MCNA with the U.S. FDA on June 29, 2015 and is seeking, upon marketing approval in the U.S., to make MCNA available for patients and their physicians. Our ultimate goal is to transform the treatment landscape and prolong and improve the lives of those affected by bladder cancer, one of the most common types of cancers today.

United Health Programs

United Health Programs is a Plainview, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.